In Vitro Studies in Nickel Allergy: Diagnostic Value of a Dual Parameter Analysis  by Blomberg-Van Der Flier, Mary Von et al.
In Vitro Studies in Nickel Allergy: Diagnostic Value 
of a Dual Parameter Analysis 
M ary von Blo mberg-van der Flier, M.Se., Cees K. H . van der Burg , M.D ., Odette Pos, B.Se. , 
E ll a M . va n de Plassche-Boers, M .D ., D erk P . Bruynzeel, M.D ., Ph.D ., Gianni Garotta, Ph.D., and 
Rik J Scheper, Ph .D. 
Depar tlll ellts of Patho logy (M vI3-vd F, 0 1', E M vd l'- B, RJ S) and Derm ato logy (C KH vdB , DPJ3), Free Uni ve rsity Hospital, 
Amsterdam, T he N etherbnds, and Centra l Research Units, F Hoffm ann- La Roche & Co., Ltd. (GG), Basel , Switze rl and 
A co mpari son was m ad e be tween th e di ag n os ti c valu e o f 
assayi n g ni ckel-indu ced ly mph ocy te pro life ra ti o n (l y m-
phocy te trans fo rm atio n tes t , L TT) and mig ra ti o n inhibi-
tio n fac to r (MIF) pro du cti o n in ni ckel contact sen sitivity. 
Al t h o u g h ly mph ocy te pro life ra ti o n was sig nifi ca ntl y in-
creased in th e g ro up of pa ti ents w ith sk in tes t reactivity to 
ni ckel , posit ive L T T w ere a lso frequ entl y fo und in skin 
tes t-nega ti ve s ubj ects: in 63% o f subj ects with and in 30 % 
of subj ects w itho ut a hi sto r y o f m e ta l a llergy. T hi s wo uld 
limi t th e va lu e o f th e L TT as a n in vi tro correla te of skin 
tes t reacti v ity. H o w eve r , in ce rta in pa ti ents pos itive lym-
phocy te tra nsfo rmati o n ma y re veal ni cke l sen s iti za tio n a t 
a time of un detectable skin reacti v ity. 
Da ta o b ta ined w ith th e m acro phage mi g ra ti o n inh ibiti o n 
tes t (MMIT) sh owed a good co rre lati o n with ni ckel patch 
Sin ce ni ckel is the most co mm on co ntact sensiti zer in hum ans, ava ilabi lity of di ag '.lOs ti c in vitro tes ts fo r ni ckel alle rgy would be of g reat impo rtance. Data o btained from th e li te rature rega rd in g the usc of lymphocy te transform ation tes ts (L T T ) fo r thi s purpose, arc listed in 
T able I /1 - 151. Stati sti ca l differences between g ro ups o f ni ckcl-
sensitive pa tients and hea lth y contro ls were usuall y fo und . N ever-
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A bbreviatio ll s: 
Con A: concanava lin A 
DTH : delayed- type hypersensiti vi ty 
FCS: feta l ca lf serUIll 
L1 F: leukocyte migration inhi bition facto r 
LK: Iym ph ok ine 
LMIT: leukocyte mig ration inhibition test(s) 
L TT: lym phocyte t ransfo rmatio n tes t (s) 
MI : m ig ration inh ibitio n 
MI F: mac rop hage mig ration inhibi tion fac tor 
MMIT: macro ph age migrat ion inh ib itio n tes t(s) 
PEL: pe ri pheral blood Iymphocyte(s) 
PBS: phosphate-buffe red sa line 
PM N : polymorphonuclea r 
SI: stim ulatio n index 
tes t reacti o ns . A ccura te d e te rmination of MIF beca m e fea-
s ible b y us in g cell s fro m th e hum an monocytoid cell line 
U 937 as ta rget cell s in a mi c ro drople t aga rose assa y . Usin g 
this MMIT, positive reacti o ns o ccurred in 13% of the health y 
contro ls and fa lse-nega tive r eac ti o n s w e re fo und in 26% o f 
pa ti ents w ith p ositive skin tes t reacti vity to ni ckel. 
A s LTT and MMIT data appea red to be only w ea k ly 
correlated in the individua ls tes ted , a du al parameter an al-
ys is was perfo rmed . An excellent correlation [p = 1.8 (1 0 - 8) ] 
w as fo und be tween s kin tes t and in v itro reactivity for 
indi vidua ls with m atchin g in vitro resu lts (60% of all in-
dividu als tes te d). In th ose individu als with di scordant i.n 
v itro data , skin testin g wi ll rem ain indi spen sable for di-
agnos in g ni ckel a ll e rg y. J filli es! D erwa!o/ 88:362- 368, 1987 
theless, the indi vidual diagnosti c va lue of thi s assay was limited, 
parti cularl y by a hi gh in cidcnce o f false-positi ve rcactio ns. 
As anti gen-indu ccd Iymph o kin e (LK) relcase represents a cru-
cial stcp in th e develo pmcnt o ftyp c IV hypersensitivity reactions, 
one wo uld ex pect assays measurin g ni ckel-in du ced LK produ c-
ti on to be most suitabl e as dia gnostic tes ts in nickel allergy . [t has 
indeed been repo rted that lymphocy tes from nickcl-allergic pa-
tients m ay produ ce leuk ocyte mi gratio n inhibiti on factor (L1F) in 
vitro in the presencc of nickel-pro tcin conju gates [1 6, ·[ 7] o r free 
ni ckel sa lts [1 8-20 1. Fro m T ablc [[ it is clear th at no consistent 
results were o btained . This mi ght be due to thc usc o fullseparated 
bu ffy coats fo r simu ltaneous LlF production and mig ration (1 -
phase leucocyte mi gratio n inhibition tes t, LM[T) . In addition, 
th e sho rt culture periods (up to 1 day) in these assays ma y not 
have becn suffi cient fo r adequate ni ckcl prescntati o n by accessory 
cell s, Iympho kin c release by effector ccll s, and inhibition o f mi-
g ratin g ta rget cell s. 
[n th e present study , therefo re , w e adaptcd a 2-phase protocol 
in w hi ch peripheral blood lymphocytes (PBL) w ere precultured 
to all ow fo r m acro phage mi g ratio n inhibitio n facto r (MIF) pro-
du ction . Subsequentl y, MIF activity was measurcd on a ho m og-
enous populatio n o f ta rgct cells. In preliminary ex perimcnts 3 
presentl y ava ilabl e hum.an m yelo/ mon ocy ti c ccll lin es (KG-l (22], 
HL60 r231, and U 937 r24,25]) w ere screened fo r M[F sensitivity. 
U937 cells, found to provide o ptim al targets, w ere then used to 
eva luate the diagnosti c value o f a 2-phase ma crophage mi g ration 
inhibiti on tes t (MM IT ) in ni ckel allergy . The MMIT data w ere 
co mpared w ith lymphocy te transfo rmatio n data as to their cor-
relation w ith sk in tes t reactivity . [n addition , considerin g that 
bo th in vitro param eters (MIF produ ction and lymph ocyte pro-
0022-202X/87/S03.S0 Copy right © 1987 by T he Society fo r In ves tigative Dermato logy. In c. 
362 
VOL. 88. NO . 4 APRIL 1987 IN VITRO TESTS IN NIC KEL ALLERGY 363 
Table I. Lymphocyte Transformation in the Diagnosis of Nickel Allergy-Review of Literature 
Results 
Patients Control Group 
In Vitro Test 
% False % False 
Year First Author Reference Antigen Concentration" N i> N egative' N i> Positived Sign' 
1962 Aspegren [1] NiCIz 100 /LM 15 0 15 100 
1970 Pappas [2 1 NiA c 112 '/LM 3 0 8 100 
1970 M acLeod [3] NiSO. 50 /LM 12 17 14 0 + 
1972 Form an 14] NiSO. 18 II 12 66 + 
1972 Hutchinson 151 NiSO./ NiAc 50/LM 8 25 7 14 + 
1973 Mi ll ikan [6 1 NiCL2 40 /LM 8 0 6 0 + 
1975 G imenez 17] NiSO. 0.65/65 /LM 25 0 10 0 + 
1976 Kim 181 NiSO./ NiAc 40 /LM 21 0 17 < 10 + 
1978 Svej gaard 19] Ni SO. 20 /LM 8 13 9 11 + 
1979 Veien 110 1 NiSO. 36/72 /LM 8 13 4 25 + 
1980 S i I ven no incn-Kassi nen 111 J NiSO" 8/40 /LM 35 II 49 20 + 
1981 AI-Tawil 11 2] NiSO, 24/LM 13 15 9 22 + 
1982 Ma cLeod 11 3J NiSO., 50 /LM 6 33 6 33 
1984 Nordlind 11 4] NiSO" 20 /LM 10 0 10 40 + 
1985 AI-Tawil [1 5] NiSO" 80 /LM 4 1 15 34 32 + 
1987 Blomberg IThis pa pc rl NiSO., 7- 80 /LM 27 7 23 39 + 
"Nickel concentrati ons showin g :111 optimal d ifference between patient and co ntrol g roups. 
bNull1ber of individuals tested . 
'Stimulation index (51) :s 2 in nickel-allergic patients. 
"51 > 2 in health y controls. 
'Statisti cal differences between groups of nickel-a llergic pa tients and healthy cont rols : +. 
liferation) re late to different phases of the cell-mediated immune 
response (rep resenting effector and memory functions, respec-
tively), a dual parameter analysis was performed. 
MATERIALS AND METHODS 
Donors Twenty-seven nickel-allergic indi viduals showin g pos-
itive nickel patch tests (13 + and 14 + + or + + +) were ran-
dom ly selected from paticnts visiting our Allergy C linic, and from 
junior hairdressers w ho had been sk in tested in a parallel stud y 
on occupational all ergy. Th ir ty-one negative control s were avaiJ-
ab le from the same groups, including 8 skin test-negati ve indi-
viduals w ith a positive history of meta l allergy . Cord blood sam-
ples, kindly prov idcd by our Departm ent of Obstetrics, were 
used as a source of nonsensitized con tro l lymphocytes. 
Skin Tests Patch rests were performed w ith 5% NiS0 4 in 
petrolatum. Patches were removed after 48 h and the reactions 
were read 15 min later and graded according to Fregert [26]: 
nega ti ve (-), weak (nonvesicular) reactions (+), and strong 
(edematous and vesicular) reactions (+ +), or even bullous re-
actions (+ + +) . 
Lymphocyte Transformation Tests Mononuclea r cells were 
isolated fro l11 hepa rinized blood by Ficoll-isopaq ue centrifuga tion 
prior to or 2-3 weeks after skin testing and cryopreserved . The 
cells were cultured in round-bottomed microtiter plates (105 cells 
in a final volume of 150 J.LI per well in sixfold) in RPMl 1640, 
supplemented w ith HEPES, antibiotics, and either 20% inacti-
vated pooled human serum o r 20% inactivated autologous serum . 
NiSO",61-hO (Merck , purity > 99% ) was used as antigen in the 
Table II. LlF/ MIF Production in the Diagnosis of Nickel Allergy-Review of Literature 
In V itro Test 
First 
Y ear Autho r Reference Assay Antigen C oncentration" 
1975 Mirza [1 6] I-phase LMIT NiSO. 
Ni-BSA 
1976 T hulin 11 7] I-phase LMIT NiC I2 
Ni-HSA 
1976 Jo rdan [1 8] I-phase LMIT NiSO" 
1976 M acLeod rt 91 I-phase LMIT NiSO" 
2-phasc LM IT N iSO" 
1977 Swoboda 1201 I-phase LM IT NiSO" 
1983 N o rdlind 121] I -phase LMIT NiSO " 
1984 Blo mberg [T his paper] 2-phase MMIT NiSO" 
LIF = leuk oc yte mi g ration inhibition f., cto r. 
M IF = ma cro pha ge mig ratio n in hibit io n f., cto r. 
LM IT = leukocy te migration inhibition test. 
MM IT = macrophage migration inhibition test. 
BSA = bo vine serum album in . 
H S A = 11ll rnan serum :1 lbumin. 
"' Nickel concentratio ns sho w in g :t il optim al difference between patient and con tro l g roups . 
bNulllbcr o f indi v idua ls tested. 
I"Migrati on inhibition < 20% in nickel-a llergic patients. 
"Migration in hibition 2: 20% in healthy contro ls. 
'Statistica l differences between groups of nickel-a llergic patients and healthy controls: +. 
f Mig ra rioll inhibition > 10% lco nsidcrcd as posit ive . 
320 /LM 
294 /LM 
844 /LM 
844 /LM 
468 /LM 
50 /LM 
50 /LM 
400 /LM 
36 /LM 
7-40 /LM 
Patients Control Groups 
% False % False 
N " Negati ve' N" Pos itived Sig n' 
II 73 6 17 
15 0 13 31 + 
12 58 II 55 
10 30 9 22 + 
10 0 10 0 + 
10 10 
3 3 
21 14 2 1 10 + 
10 100 10 0 
27 26r 23 13r + 
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culturcs in fina l conccntration s of 0, 7, 14, 40, and 80 JL M. At day 
6 rJH]-th ym idine uptakc (1 JLC i/cuiturc with sp ac t of5 Ci/m m ol, 
in 5 h) was mcas ured usin g liquid scintill ation countin g. Nickel-
specifi c st imulation was ex presscd as 
. (mcan cpm w ith NiS04) Stimulat ion IJ1d cx (S I) = ---''-----'----------'!....-(mean cpm w ithout NiSO,,) 
Macrophage Migration Inhibition Test M ononuclear cells 
wcrc isolated as describcd abovc, and cu lturcd in con ica l 15-m l 
tubes [2.5 (10 - 6) ) in ] ml) in RPM I 1640, supplemcntcd with 
HE PES, antibi o ti cs, and 10% fetal ca lf scrum (FCS). To the 
culturcs NiS04·6H 20 was ad ded to g ive fin al concentrations of 
0, 7, 14, and 40 JLM. The MI F-containin g supernatants for test in g 
va ri ous target cel l lines were prepared by add in g conca navalin A 
(Con A) (3 JLg / ml) at 24 h of culture. Supern ata nts (10 min , 2000 
g) were routin cly harves ted after 3 days ofculturc (3rC, 5% CO2 
in air) and frozcn at -20°C. For assay in g MIF activ ity, super-
natants we re d ilutcd 1:2 with fresh culture medium containin g 
10% FCS. 
In order to identify the most suitable ta rgc t cells for mig ration 
inhibiti on , the conventional capil lary method was used [27). Three 
hum an cel l lin cs we rc tes tcd: KG-l , a myeloblast leukemia line 
of g ranulocy ti c nature [22]; HL-60, a mo no myelocy tic cell line 
ca pable of diffcrentiat ion to either g ranulocytes or macrophages 
[23]; and U 937, a relat ive ly well-diffe rentiated monocyte-like cell 
lin e [251· 
Ce lls we re harvested in log-phase grow th and washed twicc 
before settin g up the mig ration assays. 
For pat ient studies, the U937 cell line was selected and a fast 
agarose-dro plet as&ay was adapted accordin g to T hurm an et al 
[281. In brief, ce ll pellets were resuspended [2(107) cell s/m l, 37°C] 
in 0.2% agarose. This was prepared by disso lvin g 20 mg sea-
plaque agarose of low gell in g temperature (Marine Co ll o ids) in 
1 ml phosphate-buffered sa line (PBS) at 120°C and di lutin g it 10 
timcs w ith RPMI 1640, 10% FC5, and antib iotics. 
From this suspension 1-JLI dropl ets were placed in fl at- bot-
tom cd micro plates usin g a Hamilton repeatin g dispense r with 
0.05-ml gas-tig ht sy rin ge. After so lidifyin g (10-20 min , 4°C) the 
droplets we re overl aid w ith 100 JLI test fluid (a ll tests in fivefo ld , 
thc o uter wells were not used). Anti gen-stimulated supernatants 
and their contro ls were always tested in th e sa me mi crotiter plate 
in order to red uce test variation. After in cubation of the covered 
pl ates during 21 h at 37°C w ith 5% CO2 in air, mig ration areas 
were measured usin g a proj ection mi cros co pe. M IF production 
was exp ressed as % mi gration inhibitio n (MI ): 
MI = 100 _ 100 X (mea n area in cultures with Ni SO,,) % 
(mean area in cultures without NiS04) 
Statistics Differences between tes t res ults in different patient 
g roups were considered to be sig ni ficant w hen p < 0.05 in the 
non para metrica l Wilcoxon tes t. Diffe rences in frequ ency were 
eva luated usin g the Fisher's exact test. For sta tisti ca l eva luat ion 
th e LTT was cons idered positive w hen 51 > 2 and the MM IT 
w hen MI > 10%. 
RESULTS 
Nickel-Specific LTT in Relation to Skin Test Resul ts Lym-
phocyte transform ation tests were routinel y performed in the 
presence of different concentrations (7-80 JLM ) ofN iSO" in pooled 
hom ologous serum . Fo r each don o r th e m aximum SI from this 
dose-response curve is shown in Fi g 1. The concentrations of 
NiS04 at w hich optimal lympho cyte pro liferat ion occurred did 
no t differ between skin test-positive patients and hea lthy controls . 
A concentrati on of 40 JLM NiS04 resu lted in an SI > 2 in 33 out 
of 38 L TT respo nd ers and was optimal in 20 o ut of th ese 38 
individuals . Wh en co rd blood lymphocytes were used to screen 
for potential mitogenicity of NiSO'h no in creased thymidin e up-
take co uld be detected. In contrast, hi gh stimu lat io n indi ces were 
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Figure 1. Nickel-specific lymphocyte transform ation in relation to skin 
test resul ts. '/) . Maximum SI from LTT with 7-80 J.tM NiSO.,. 2), Forty-
eight hour readin g of patch tes ts with 5% NiSo •. 3), Wilcoxon test. 
Indi viduals without a history of meta l allergy arc represcnted by opell 
circles, patients with a history of mct31 allergy by closed circles. 
frequently obse rved in the skin test-positive patient groups, lead-
in g to sta tistica l differences with the skin test- nega tive group 
[Fisher 's p = 3.9 (10 - 5) ] . Moreover, patients with strong (+ + 
or + + +) sk in tes t reactivity showed hi gher in vitro responses 
to nickel than did patients w ith w ea k (+) sk in reactions, sug-
Table III. Sensitivity of M yelo/ M onocytic Cell Lines , 
Human Polymorphonuclear (PMN) Cell s, and Gu inea Pig 
Peritonea l M acrophages to Hum an Ma crophage Mi gration 
Inhibition Factor 
U937 
KG-I 
HL-60 
Target Cell 
Hum3n PMN cc lls 
Guinea pig peritoneal 
macrophagcs 
Maximal Migration 
Inhibition (%) 
78 
72 
44 
40 
56 
Dilution of Lymphokine 
Preparation That 
Produces 30% of 
Migration Inhibition 
1 :50 
1 :26 
1:32 
1 :20 
1 :9 
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I gesting a positive co rrelation between nickel patch tes t and L T T 
da ta. Essentiall y similar results were o btained w hen autologous 
sera were used to supplem ent the culture media (data no t shown) . 
However, a rem arkabl y high percentage (39% ) of skin tes t-
negative individuals showed significant lymphocyte stimulation 
in vitro. An importan t contribution to this high percentage is 
made by the group o f ni ckel skin tes t-negative individuals w ith 
a positive history of m etal allergy. 
Sensitivity of Three Leukemic Cell Lines for Human MIF 
Conventional target cells fo r clinica l LIF and MIF assa ys (human 
po lymorph onuclea r (PMN) cells and guinea pig peritoneal m ac-
ro phages, respectively) show considerable dono r-dependent vari-
ations in bo th their migrato ry capacity and responsiveness to 
LIF/ MIF. T herefo re, w e in ves tiga ted w hich of the human leu-
kemic cell lines-KG1, HL60, and U 937-could be applied in a 
m igration inhibition assay . Fo r this purpose MIF-sensitivity was 
evaluated by tes tin g the res ponsiveness to a con A-induced Iy m-
p hokine preparation . From Table III it is clea r that th e mon o-
cytoid cell line U 937 provides very sensiti ve target cells. U sing 
th e U 937 cells in an aga rose microdro plet assay, tes t va ri ation 
was extrem ely lo w , allowing a mi gration inhibition exceeding 
10% to be taken as signifi can t . 
Nickel- Induced Production ofMIF in Relation to Skin Test 
Results The capacity o f lymphocy tes fro m nickel-allergic pa-
tients to produ ce MIF upon stimu lation w ith NiS0 4 was tes ted 
us ing the m o nocytoid cell line U 937 as indica tor cells. T he NiS0 4 
concentratio ns, rangin g from 0- 80 fJ-M , had no effect on either 
migration o r M IF sensitivity of the U 937 cell line (data not shown) . 
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n 31 13 14 
mean±sd 1.3 ± 8.2 11.5 ± 6.1 24.7 ± 15.3 
median 4 13 24 
statistics 4) I II I P<O.OI P<OO5 
Figure 2. Nickel-specific MIF production in relation to skin test results. 
1), Maximum migration inhibition from cultures with 7-40 /LM NiS04 • 
2), Forty-eight hour reading of patch tes ts with 5% NiS0 4. 3), Healthy 
controls with negati ve nickel patch test reactions with (closed circles) or 
w ithout (opell circles) a history of metal allergy . 4). Wilcoxon tcst. 
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Table IV. M acrophage Migration Inhibition Facto r 
Produ ction and Lymphocyte T ransfo rmation in Nickel-Allerg ic 
Patients and H ealthy Contro ls 
Macrophage 
Lymphocyte Migration 
Patient Transformation Inhibition Test 
Code Skin Tes t" Test (LTT)b (MMIT) ' 
Abes 0 4.6 - 15 
Liu 0 1.7 - 14 
Worm 0 9.4 - 14 
Wecr 0 1. 0 - 12 
Y dem 0 1. 4 - 10 
Celi 0 2.6 6 
T imm 0 8.8 - 2 
Hoge 0 1.1 2 
Vdlc 0 1. 2 0 
Goud 0 2.8 1 
Hoek 0 1. 4 4 
Lank 0 4.5 4 
TO Ll w 0 1.2 4 
Tbor 0 1. 8 4 
Enge 0 1.0 4 
Buis 0 1. 4 5 
Vgel 0 1.3 6 
Krij 0 1.3 7 
Kemp 0 2.0 8 
Mekk 0 1.1 10 
Laut 0 1.7 13 
Poor 0 4. 1 17 
Fort 0 1. 2 18 
Schr 0" 1. 8 6 
Pete 0" 2.5 - 1 
Veer 0" 14.2 1 
Vdij 0" 1.0 2 
Stie 0,1 2.9 3 
O ud 0" 1. 5 3 
Vdme 0,1 2.9 4 
Sjau 0" 11. 5 6 
Vers + 32 3 
Kwa m + 4.7 7 
Jagn + 2.9 4 
Debi + 2. 1 9 
Duri + 2. 1 11 
Fida + 9.6 12 
T hak + 3.9 13 
Dhaa + 4.3 13 
Oost + 6. 1 14 
Mulk + 2.5 15 
Pepe + 2.2 16 
Brou + 9. 1 16 
Zwan + 1.3 23 
Wiel ++ 2.9 
Has +++ 7.8 2 
Bakk ++ 11.2 6 
Stol +++ 17.2 16 
Dboe ++ 1. 4 15 
Bons +++ 24.0 18 
Pold ++ 5.4 23 
Koet ++ 7.0 25 
Albe ++ 2.6 31 
Eve! +++ 13.8 38 
Vdam ++ 10. 1 38 
Vdwe ++ 8.3 39 
Veen +++ 2.8 47 
Dpre +++ 9.4 48 
"Fo rry-eight hour read ing of NiSO" patch test reactions. 
' Maximum stimulation ind ex from L TT with 7-80 JkM NiSO, in pooled ho-
mologo lls serum. 
(Max imum mi grarion inhibition fro m MMIT w ith 7-40 JL M N iSO-\. 
"Positi ve history of metal allergy. 
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Figure 2 shows the resul ts of th e MMIT, w hen testi ng nickel-
all erg ic patients and hea lthy contro ls. Ma ximum MI indices, ob-
tain ed w ith 7-40 J.LM NiS04 , are g iven in relati on to th e NiS04 
patch test reactions. In patch tes t-positive pati ents more MIF was 
prod uced than in patch test-negative individuals [Fisher'S p = 
2.2 (10 - 6)]. M oreover, nickel-induced MIF production positively 
correlated with the streng th of the skin test react ion, as judged 
by a 2-step stati sti ca l analysis. In th e sk in test-nega tive indi vid uals 
w ith a positive hi sto ry of metal allergy th e MMIT data co mpl etely 
reflected the lack of sk in reacti vity. 
With respect to the d iagnosti c va lue of the presen t 2-phase 
MMIT in nickel allergy, our data show that in spite of the positive 
corre lat ion w ith skin test reactivity, false-negative reactions oc-
curred in 7/27 ni ckel- hypersensitive donors (26%) and fa lse-pos-
iti ve reactions in 3/23 hea lth y controls (13%). 
Diagnostic Value of Paired LTT and MMIT Data In Table 
IV , LTT and MMIT data are listed fo r all individual donors, 
grouped accordin g to skin test reactivity. Although no quanti-
tative co rrel ati on was fo und between LTT and MMIT (,. = 0.16), 
the all-or-none correlati on was positi ve (Fisher's p = 0.01) . The 
fac t , however, that many individuals (22/58) showed discordant 
in vitro res ul ts prompted us to eva luate whether a combination 
of LTT and MMIT data would improve th e di agnostic value of 
in vitro testin g for nickel allergy . 
Ta ble V shows the res ults of such a dual param eter analysis. 
[n this tab le the in vit ro test results in th e different patient groups 
are compared with those in hea lth y control s (both skin tes t and 
history negati ve, n = 23). By using 2 in vitro para meters, a better 
discrimination was o btained between ni ckel skin test- positive 
patients and health y controls (Table V) . 
A reliable indi vidual diagnosis, however, could be made on ly 
in patien ts w ith matchin g in vitro results: none of the all ergic 
patients showed 2 nega tive in vitro tes ts, whereas onl y 1 indi-
vidual in the hea lth y contro l group had 2 positi ve in vitro tests. 
D ISC USSION 
The central ro le of helper T lymphocytes both in the induction 
and elicitation phase of con tact hypersensitivity is now beco min g 
w ell es tablished. All nickel- specifi c clones selected from periph-
eral blood of nickel-a llergic patients were of the OKT3 +, 4 + , 8 - , 
Leu 7- phenotype 129]. T hese clones not only proliferated upon 
contac t w ith ni ckel, th ey also produced va riou s LK . Interes tingly , 
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no obvious co rrelation between the deg ree of ex pression of these 
two cell fun ctions was observed when testin g different nickel-
specifi c clones [29]. In polyclona l cell suspensions like PBL, th ere-
fore, this would result in a large overlap between proliferative 
and productive fun ctions . It can, however, not be excluded that 
different pati ents preferentiall y ex press either o f these cell fun c-
ti ons, dependin g for instan ce on their recen t history of all ergenic 
contacts. Obviously, techni ca l factors, li ke th e duration of the 
assay may create an add itional di chotomy between results from 
tests fo r these fun ctions. In line with these considerations our 
present results indi ca te that L TT and MMIT data can show dif-
ferent patterns in the patient groups studied. 
Although ni ckel-specific L TT correlated well w ith skin test 
reacti vity in groups of patients , th e value of the L TT for individual 
diagnosis of ni ckel allergy was restricted by the hi gh percen tage 
of positive tests found in hea lth y controls. As reported ea rlier by 
AI-Tawil , Marcusson, and Moller [1 2], NiS04 concentrations of 
7-80 J.LM were unable to stimulate proliferation of co rd blood 
lymphocytes in 6-day cultures. Using chi ldren 's blood lympho-
cy tes, kn own to be more sensitive to mitogens, N ordlind and 
Henze [30] observed a weak stimulation (up to SI = 2. 1) under 
similar culture conditions, suggesting mitogenicity of NiS0 4 . In 
our hands, NiS04 was not mitogenic in cultures of T-helper 
clones selected for nonrelated (ma laria) anti gens (data not shown). 
Moreover the majority of hea lthy controls did not react to NiS04 
at all. We must th erefore co nclude that in a substantial number 
of skin test-nega tive individuals nickel-sensiti zed lymphocytes 
circulate that proliferate upon conta ct w ith ni ckel but are not yet 
able to generate a clinically manifest allergic reaction. A follow-
up study is now being ca rried out to in vestiga te the predictive 
va lue of the pos itive nickel L TT for future development of nickel 
contact dermatitis. 
As to the perfo rm ance of th e MM IT, it is cl ea r from our results 
that the monocytoid cell line U 937 is most sensitive for human 
MIF, as compared w ith th e HL-60 and KG-1 cell lines . T his ag rees 
with recen t findin gs of Liu et al [31] who demonstrated the pres-
ence of substantial amounts of MIF- receptor molecules on the 
U937 cell membrane. 
Using U937 target cell s in th e mi crodroplet agarose MMIT, 
th e assay is rap id and easy to perform, and requires only small 
amounts of blood (1 ml /a nti gen concentration). Reproducible 
res ults are obtained, not on ly with nickel, but also with mi crobial 
antigens [32]. Moreover, the 2-phase system allows lymphocytes 
to be cryopreserved and MIF supernatants to be stored at - 200e 
Table V. T he Diagnosti c Va lue of Combinin g Res ults from Two In Vitro Tests in Nickel All ergy (L TT and MMIT) As 
Compared to Resul ts from Either Test Al one 
Sing le Para m ete r Anal ys is 
LTT Pas 
Patient Groups LTT Pas" MMIT POSh and MMIT Pas 
Skin test nega tive 
H istory ncg' n = 23 7/23 3/23 \ /23 
History pas n = 8 518 0/8 0/8 
I1. S . d I1 .S. I1.S. 
Total n = 3 1 12/3 1 3/13 1/31 
Sk in tcst positive" 
+ n = 13 12/ 13 9/13 8/13 
[4(10 - 4) ] " [10 - 3] 13(10 - 4)1 
++ 1+++ n 14 13/14 11 / 14 10/ 14 
12(10- ")]" 11 0 - 4 ] [3(10- 5)1 
Tota l 25/27 20/27 18/27 
15(10- ")1 [2(10 - S) ] [4(10 - (') ] 
' Lymp hocyte transformation test (L TT) was considered positive w hen stimulation index > 2.0. 
bMacrophagc mig ratio n jnhibition tcst (MM IT) was considered positive w hen mi g ration inhibition > 100/0. 
'Hi sto ry of metal allerg y. 
Dual Param ete r Analys is 
LTT andlo r LTT N eg 
MMIT Pas and MMIT Neg 
9/23 14/23 
5/8 3/8 
n.s. n.s . 
14/31 17/31 
13113 0/13 
[2(1 0 - 4) ] [2(10 - ")] 
14/14 0113 
[1 0 - "] [1 0 - "] 
27/27 0/27 
19(10- 7)1 19(10 - 7) ] 
' All p va lues given between brackets arc ob tained by co mparin g the test res ults from the different patient gro ups with those from skin test-nega ti ve, history-nega ti ve 
hC:l lth y contro ls. lI sing th e Fisher exact test. 
' Fo rty-eight hour readin g of NiSO, patch tes t reaction . 
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wi thout loss of activity for severa l months, enabling repea ted 
testing and longitudinal studies. 
A highl y significant correlation was found between ni ckel-in-
duced MIF release and skin tes t rea ctivity to nickel. Rega rding 
the extremely low intraexperimental va riation in migration o f the 
U937 cell s, an inhibition exceedin g 10% should be considered as 
significant. Using thi s criterion, the MMIT di scriminated better 
between skin test-positive and skin test-nega tive patients than 
did the LTT. 
A dual parameter anal ysis, by combining the results of both 
LTT and MMIT, allows a reliable diagnosis in about 60% of the 
individuals tested, ni ckel all ergy being either excluded (both in 
vitro assays nega tive) or demonstrated (bo th assays positive) (Ta-
ble V) . However, in 40% of the individuals showing onl y 1 
pOsitive test , the in vitro studies did not permit definite conclu-
sions. 
Discrepancies between in vivo skin reactivity and in vitro blood 
lymphocyte res ponses are also encountered w ith various micro-
bial antigens [32] and are probabl y related to compartmentali-
za tion of immune res ponsiveness: local retention of ni ckel-specifi c 
ly mphocy tes at distin ct anatomic sites mi ght cause fa lse nega tive 
in vitro reactions of PBL. False nega tive skin reactions on the 
Other hand may be du e to local or sys temic desensitization [33]. 
Differences in sensitivity of the in vitro and in vivo assays ma y 
fu rther add to such discrepancies . In this context it should be 
stressed th at in the present study a routin e patch tes t procedure 
was used with only a single concentration of NiS04 , as recom-
mended by the IC DRG (Internati onal Contact Dermatitis Re-
search Group) . The vehicle used in this procedure (petrolatum) 
was recentl y sugges ted not to be optimal for NiSO" skin testing 
[34,35] . 
From our study the followin g conclusions can be drawn: 
1. Assessment o f peripheral blood lymphocytes for ni ckel-in-
du ced MIF release has become feasible by the use of a 2-
phase system with U937 cells as MIF targets. 
2. The MMIT is less sensitive, but more specifi c, than the LTT 
for predictin g skin reactivity to ni ckel. 
3. Dual parameter analysis, by combining L TT and MMIT 
results, all ows a reli able diagnos is in the majority of indi-
viduals tes ted for nickel all ergy . 
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excel/wt techllical assisttlll Ce , Pro! ). Oort for his critical rel/ielll of the ll l<lIIt/script , 
and Desi,.,ie de jong for seCl'etorial assisto llce. 
REFERENCES 
1. Aspegren N, Rorsman H: Sho rt te rm culture of leukocyte in nickel 
hypersensitivity . Acta Derm Venereol (Stockh) 42:412- 417, 1962 
2. Pappas A, Orfanos CE, Bertram R: N on-specific lymphocyte trans-
form ation in vitro by nicke l acetate. j Inves t DermatoI 55:198-200, 
1970 
3 . MacLeod TM , Hutchinson F, lb fR e EJ: The uptake oflabelled th y-
midine by leukocy tes of nickel sensitive patients. Br ] Dermato l 
82:487-492, 1970 
4. Forman L, Alexander S: Nickel antibodies. Br] DermatoI 87:320-326, 
1972 
5. Hutchinson F, RafRe Ej, MacLeod TM: The specifi city of lympho-
cytic transformation in vitro by nickel salts in nickel sensitive 
subj ects. j In ves t Dermatol 58:362-365, 1972 
6. Millikan LE, Conway F, Foote ]E: In vitro stlldies o f contact hy-
persensitivity: lymphocyte transformation in nickel sensitivity. J 
In vest Dermatol 60:88-90, 1973 
7 . Gimenez- Ca marasa ]M, Ga rcia-Calderon P, Asensio ] , De Moragas 
JM : Lymphocyte transformation test in allergic contact nickel der-
matiti s. Br J D crmato l 92:9-15, 1975 
8. Kim C W, Schopf E: A comparative stlld y of nickel hypersensitivity 
by the lymphocyte transformat ion test in atopic and non-a topic 
dermatitis. Arch Dermato l Res 257:57-65, 1976 
IN VIT RO TEST S IN NIC KEL ALLERGY 367 
9. Svejgaa rd E, Morling N , Svejgaard A, Veien NK: Lymph ocyte 
transformation induced by nickel sulphate: an in vitro stud y of 
subjects with and w ithout a positive nickel patch tes t. Acta Derm 
Venereo l (S tockh) 58:245-250, 1978 
10. Veien NK, Svejgaa rd E, Menne T: In vitro lymphocyte transfo r-
mation to nickel: a stLId y of nickel sensitive patients before and 
after epicutaneous and ora l challenge with nickel. Acta Derm Ve-
nereol (Stockh) 59:447-45 1, 1979 
11 . Silvennoinen-Kassinen S: Lymphocyte transform ation in nickel al-
lergy : amplificat ion ofT lymphocyte responses to nickel sulphate 
by macrophages in vitro. Scand] Immunol 12:6 1-65, 1980 
12. AI-Tawil NG, Marcusson ]A, Moller E: Lymphocyte transforma-
tion tes t in patients w ith nickel sensiti vi ty: an aid to diagnosis. 
Acta Derm Venereol (Stockh) 61:511 -515, 198 '1 
13. MacLeod TM, Hutchinson F, RafRe EJ: In vitro blastogenic Iym-
phokine activity in nickel allergy. Acta DCI'm Venereol (Stock h) 
62:249-250, 1982 
14. N ordlind K: Lymphocyte transformation test in diagnosis of nickel 
allergy. A comparison between the separation of peripheral blood 
lymphocytes on Ficoll-paque, Perco ll or by grav ity sedimentation. 
lnt Arch Allergy Appl Im munol 73: 151-154, 1984 
15. AI-Tawil N G, Berggren G, Emtcs tam L, Fransson] , ] ernselius R, 
Marcusson ]A: Correlation between quantitative in vivo and in 
vitro responses in nickel-a llergic patients. Acta Derm Venereol 
(Stockh) 65:385-389, 1985 
16. Mirza AM , Perera MG, Maccia C A, Dziubynskyj OG, Bern stein 
IL: Leuk ocyte migration inhibition in ni ckel dermatitis. Int Arch 
Allergy Appl Immunol 49:782-788, 1975 
17. Thu lin H: The leukocyte migration test in nickel contact dermatitis. 
Ac ta DCI'm Venereol (Stock h) 56:377-380, 1976 
18. Jo rdan WI' , Dvorak J: Leukocyte migration inhibition assay (L1 F) 
in nickel contact dermatitis. Arch Dcrmato I 112:1 741-1744, 1976 
19. MacLeod T M, Hutchinson F, RafRe EJ: The leukocyte migration 
inhi bition tes t in allerg ic nickel contact dermatitis. Br] DerI1lato l 
94 :63- 64, 1976 
20. Von Swoboda B, FritzJ , Ludvan M: Nickela llergie und Leukozyten-
Migrations-Hemmung. Dermatol Mona tsschr 163:208-2 '12, 1977 
21. N ordlind K, Sandberg G: Leukocytes from patients allergic to chro-
mium and nickel exa mined by the scaled ca pi llary migration tech-
nique. Int Arch Allergy Appl Immunol 70:30- 33, 1983 
22. KoefRer HI' , Golde DW: Acute myelogenous leukemia: a hum an 
cell line responsive to colony stimulating activity. Science 200: 
11 53-1154,1978 
23. Coll ins S], Galpo RC, Ga llagher RE: ContinLioLis g rowth and dif-
ferentiation of hum an myelo id leukaemic cells in suspension cul-
ture. Nature 270:347-349, 1977 
24. Singh K, Khan A: The usefulness o f a monocytoid ce ll line (U937) 
in the macrophage inhibition assay. J e lin Hcmato l O ncol 12: 
29-37, 1982 
25. Sundstrom C, Nilsson K: Es tablishmen t and characteri za tion of a 
human histiocytic lymphoma cell line (U-937). Int J Cancer 17: 
565-577, 1976 
26. Fregert S: Patch testing, in Manual of Contact Dermatitis. Copen-
hagen, Munksgaardm , '1981, pp 71-81 
27. D avid JR, AI-A skari S, Lawrence HSS, Tho mas L: Delayed hyper-
sensitivity in vi tro. J Immunol 93:264-273, 1964 
28. Thurman GB, Stull HB , Miller PJ , Stevenson HC, O ldham RK: 
Utilization of purified human monocytes in the aga rose dro plet 
assay measuring migration inhibito ry f.1C to rs.] Immunol Method s 
65:41-53, 1983 
29. Sinigaglia F, Scheidegger D, Ga rotta G, Scheper R] , Pletscher M, 
Lanzavecchia A: Iso lation and characteri zation of Ni-specific T cel l 
clones from patients w ith Ni-contac t derm atitis. ] Immu nol 135: 
3929-3932, 1985 . 
30. Nordlind K, Henze A: Sti mulating effect of mercuric chlo ride and 
nickel sulphate on DNA synthes is o f thymocytes and peri phera l 
blood lymphocytes in children. Int Arch Allergy Appl Illlmunol 
73:162- 165, 1984 
31. Liu DY , Yu SF, Remold HG, David ]R: Macro phage g lyco lipid 
recepto rs for human migration inhibito ry fac to r (MIF): differen-
tiated HL-60 cells exhibit MIF responsiveness and ex press sur face 
368 VON BLOMBERG-VAN DER FLIER ET AL 
glycolipids which both bind MIF and convert nonresponsive cells 
to responsive. Cell Immunol 90:605-613, 1985 
32. Van de Plassche-Boers EM , Drexhage HA, Kokje-Kleingeld M, 
Leezenberg HA: Parameters ofT-ceil mediated immunity to com-
mensa l micro-organisms in patients with chronic purulent rhi-
nosinusiti s: a co mparison between delayed type hypersensitivity 
(DTH) skin test, lymphocyte transformation tes t (LTT) and mac-
rophage migration inhibition fac tor (MIF) assay . C lin Exp Im-
munol 66: 1986 . 
THE JOU RNAL OF IN VESTIGATIV E DERMATOLOGY 
33. Boerrigter G H, Scheper RJ: Loca l and systemic desens itiza tion in-
duced by repeated epiclltaneous hapten application. J In vest Der-
matol 88:3-7, 1987 
34. Fischer T I, Maibach HI : T he thin layer rapid use epicutaneous test 
(TRU E-tes t), a new patch tes t· method w ith high accuracy. Br J 
Dermato l 11 2:63-68, 1985 
35 . Van Ketel WG : Petrolatum-a reliab le vehicle for metal allergens? 
(letter to the editor). Contact Dermatitis 7:60, 1981 
